Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of alpha-lipoic acid and N-acetylcysteine
Publication

Publications

Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of alpha-lipoic acid and N-acetylcysteine

Title
Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of alpha-lipoic acid and N-acetylcysteine
Type
Article in International Scientific Journal
Year
2012
Authors
Filipa Ponte
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rosa Sousa
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ana Paula Fernandes
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Cristina Goncalves
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Jose Barbot
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Felix Carvalho
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Beatriz Porto
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 7
Final page: 28
ISSN: 1750-1172
Publisher: Springer Nature
Scientific classification
FOS: Medical and Health sciences > Other medical sciences
Other information
Authenticus ID: P-002-A0G
Abstract (EN): Fanconi Anemia (FA) is a rare genetic disorder, characterized by progressive bone marrow failure and increased predisposition to cancer. Despite being highly heterogeneous, all FA patients are hypersensitive to alkylating agents, in particular to 1,2:3,4-diepoxybutane (DEB), and to oxidative damage. Recent studies point to defective mitochondria in FA cells, which is closely related with increased production of reactive oxygen species (ROS) and concomitant depletion of antioxidant defenses, of which glutathione is a well-known biomarker. The objective of the present work is to evaluate the putative protective effect of a-lipoic acid (alpha-LA), a mitochondrial protective agent, and N-acetylcysteine (NAC), a direct antioxidant and a known precursor for glutathione synthesis, in spontaneous and DEB-induced chromosome instability (CI) in lymphocyte cultures from FA patients. For that purpose, lymphocyte cultures from 15 FA patients and 24 healthy controls were pre-treated with 20 mu M alpha-LA, 500 mu M NAC and alpha-LA plus NAC at the same concentrations, and some of them were exposed to DEB (0.05 mu g/ml). A hundred metaphases per treatment were scored to estimate the relative frequency of spontaneous and DEB-induced chromosome breakage. The obtained results revealed that a cocktail of alpha-LA and NAC can drastically improve the genetic stability in FA lymphocytes in vitro, decreasing CI by 60% and 80% in cultures from FA patients and FA mosaic/chimera patients, respectively. These results suggest that the studied cocktail can be used as a prophylactic approach to delay progressive clinical symptoms in FA patients caused by CI, which can culminate in the delay of the progressive bone marrow failure and early cancer development.
Language: English
Type (Professor's evaluation): Scientific
Contact: filipaponte@gmail.com; bporto@icbas.up.pt
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Fibrosis: a key feature of Fabry disease with potential therapeutic implications (2013)
Another Publication in an International Scientific Journal
Weidemann, F; Sanchez Nino, MD; Politei, J; João Paulo Oliveira; Wanner, C; Warnock, DG; Ortiz, A
Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis (2013)
Another Publication in an International Scientific Journal
Lima, M
Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations (2014)
Article in International Scientific Journal
Matos L; Canals I; Dridi L; Choi Y; Maria João Ribeiro; Jordan P; Pshezhetsky AV; Grinberg D; Alves S A; Vilageliu L
Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: An observational cohort study (2015)
Article in International Scientific Journal
Patterson, MC; Mengel, E; Vanier, MT; Schwierin, B; Muller, A; Cornelisse, P; Pineda, M; Amado Fondo, A; Amraoui, Y; Andria, G; Arellano, M; Audoin, B; Azcona, C; Barr, C; Baruteau, J; Baumgartner, C; Bell, L; Bembi, B; Benneddif, K; Bernard, G...(mais 179 authors)
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document (2015)
Article in International Scientific Journal
Biegstraaten, M; Arngrimsson, R; Barbey, F; Boks, L; Cecchi, F; Deegan, PB; Feldt Rasmussen, U; Geberhiwot, T; Germain, DP; Hendriksz, C; Hughes, DA; Kantola, I; Karabul, N; Lavery, C; Linthorst, GE; Mehta, A; van de Mheen, E; João Paulo Oliveira; Parini, R; Ramaswami, U...(mais 14 authors)

See all (9)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-10 at 09:12:49 | Privacy Policy | Personal Data Protection Policy | Whistleblowing